Pharmacokinetics of ceftiofur crystalline free acid after single and multiple subcutaneous administrations in healthy alpacas (Vicugna pacos)

被引:14
作者
Dechant, J. E. [1 ]
Rowe, J. D. [2 ]
Byrne, B. A. [3 ]
Wetzlich, S. E. [4 ]
Kieu, H. T. [4 ]
Tell, L. A. [4 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA
[3] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA
[4] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
关键词
DESFUROYLCEFTIOFUR; METABOLITE; DISEASE; SODIUM; PLASMA; LLAMAS;
D O I
10.1111/j.1365-2885.2012.01395.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dechant, J. E., Rowe, J. D., Byrne, B. A., Wetzlich, S. E., Kieu, H. T., Tell, L. A. Pharmacokinetics of ceftiofur crystalline free acid after single and multiple subcutaneous administrations in healthy alpacas (Vicugna pacos). J. vet. Pharmacol. Therap.36, 122129. Six adult male alpacas received one subcutaneous administration of ceftiofur crystalline free acid (CCFA) at a dosage of 6.6mg/kg. After a washout period, the same alpacas received three subcutaneous doses of 6.6mg/kg CCFA at 5-day intervals. Blood samples collected from the jugular vein before and at multiple time points after each CCFA administration were assayed for ceftiofur- and desfuroylceftiofur-related metabolite concentrations using high-performance liquid chromatography. Pharmacokinetic disposition of CCFA was analyzed by a noncompartmental approach. Mean pharmacokinetic parameters (+/- SD) following single-dose administration of CCFA were Cmax (2.7 +/- 0.9g/mL); Tmax (36 +/- 0h); area under the curve AUC0 (199.2 +/- 42.1g center dot h/mL); terminal phase rate constant z (0.02 +/- 0.003/h); and terminal phase rate constant half-life t1/2z (44.7h; harmonic). Mean terminal pharmacokinetic parameters (+/- SD) following three administrations of CCFA were Cmax (2.0 +/- 0.4g/mL); Tmax (17.3 +/- 16.3h); AUC0 (216.8 +/- 84.5g center dot h/mL); z (0.01 +/- 0.003/h); and t1/2z (65.9h; harmonic). The terminal phase rate constant and the Tmax were significantly different between single and multiple administrations. Local reactions were noted in two alpacas following multiple CCFA administrations.
引用
收藏
页码:122 / 129
页数:8
相关论文
共 30 条
  • [1] Quantification of the BlaCMY-2 in Feces from Beef Feedlot Cattle Administered Three Different Doses of Ceftiofur in a Longitudinal Controlled Field Trial
    Alali, W. Q.
    Scott, H. M.
    Norby, B.
    Gebreyes, W.
    Loneragan, G. H.
    [J]. FOODBORNE PATHOGENS AND DISEASE, 2009, 6 (08) : 917 - 924
  • [2] [Anonymous], 2004, 141235 NADA S
  • [3] [Anonymous], 2006, 141209 NADA S
  • [4] Banting A., 1989, 788976088018 UPJ
  • [5] Cebra C.K., 2006, ANTIMICROBIAL THERAP, P529
  • [6] The disposition of five therapeutically important antimicrobial agents in llamas
    Christensen, JM
    Smith, BB
    Murdane, SB
    Hollingshead, N
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (06) : 431 - 438
  • [7] Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equine
    Collard, W. T.
    Cox, S. R.
    Lesman, S. P.
    Grover, G. S.
    Boucher, J. F.
    Hallberg, J. W.
    Robinson, J. A.
    Brown, S. A.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (05) : 476 - 481
  • [8] Pharmacokinetics of ceftiofur and metabolites after single intravenous and intramuscular administration and multiple intramuscular administrations of ceftiofur sodium to sheep
    Craigmill, AL
    Brown, SA
    Wetzlich, SE
    Gustafson, CR
    Arndt, TS
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (02) : 139 - 144
  • [9] Crane JP, 2006, J SWINE HEALTH PROD, V14, P302
  • [10] Plasma and pulmonary disposition of ceftiofur and its metabolites after intramuscular administration of ceftiofur crystalline free acid in weanling foals
    Credille, B. C.
    Giguere, S.
    Berghaus, L. J.
    Burton, A. J.
    Sturgill, T. L.
    Grover, G. S.
    Donecker, J. M.
    Brown, S. A.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2012, 35 (03) : 259 - 264